Working… Menu

Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00497952
Recruitment Status : Active, not recruiting
First Posted : July 9, 2007
Last Update Posted : October 8, 2020
Information provided by (Responsible Party):
Talaris Therapeutics Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : December 2020